TNF and rheumatoid arthritis: Treatment with recombinant IL-1Ra (anakinra) has been shown to be effective in RA [24], but its efficacy appears to be lower than that of TNF-α inhibitors [25] and its administration is frequently associated with injection-related adverse events.